Molecular Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Molecular Cancer Research 5, 165-170, February 1, 2007. Published Online First February 9, 2007;
doi: 10.1158/1541-7786.MCR-06-0398
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1541-7786.MCR-06-0398v1
5/2/165    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samowitz, W. S.
Right arrow Articles by Albertsen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samowitz, W. S.
Right arrow Articles by Albertsen, H.


Cancer Genes and Genomics

APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer

Wade S. Samowitz1, Martha L. Slattery2, Carol Sweeney2, Jennifer Herrick2, Roger K. Wolff2 and Hans Albertsen2

Departments of 1 Pathology and 2 Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah

Requests for reprints: Wade S. Samowitz, Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84132. Phone: 801-583-2787; Fax: 801-585-3831. E-mail: wade.samowitz{at}aruplab.com

Relationships between adenomatous polyposis coli (APC) mutations, BRAF V600E mutations, and the CpG island methylator phenotype (CIMP) in colon cancer have not been explored. In addition, controversies exist about the proportion of tumors with APC mutations in the mutation cluster region (MCR); how commonly APC, Ki-ras, and p53 mutations occur in the same tumor; and whether APC mutations occur in sporadic microsatellite-unstable tumors. The APC gene was therefore sequenced in 90 colonic adenocarcinomas previously evaluated for CIMP, microsatellite instability, BRAF, Ki-ras, and p53. APC mutations were inversely related to BRAF mutations (P = 0.0003) and CIMP (P = 0.02) and directly related to p53 and Ki-ras mutations (P = 0.04). Slightly more than half of APC mutations occurred outside of the MCR, and frameshift mutations were more likely than nonsense mutations to occur in the MCR (21 of 28 versus 12 of 40, P = 0.0003). APC mutations were found in sporadic microsatellite-unstable tumors and were more likely to be frameshifts in short nucleotide repeats (P = 0.007). The occurrence of APC, Ki-ras, and p53 mutations together in the same tumor was uncommon (11.1%). In conclusion, an analysis restricted to the MCR will miss more than half of APC mutations as well as mischaracterize their mutational spectrum. The conventional wisdom that most colon cancers contain APC, Ki-ras, and p53 mutations is incorrect. Microsatellite instability may precede acquisition of APC mutations in sporadic microsatellite-unstable tumors. The relationships of APC mutations to other genetic and epigenetic alterations add to the already impressive genetic heterogeneity of colon cancer. (Mol Cancer Res 2007;5(2):165–70)




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. de Vogel, B. W.C. Bongaerts, K. A.D. Wouters, A. D.M. Kester, L. J. Schouten, A. F.P.M. de Goeij, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, M. van Engeland, et al.
Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer
Carcinogenesis, September 1, 2008; 29(9): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Slattery, A. R. Folsom, R. Wolff, J. Herrick, B. J. Caan, and J. D. Potter
Transcription Factor 7-like 2 Polymorphism and Colon Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 978 - 982.
[Abstract] [Full Text] [PDF]


Home page
Bioscience HorizonsHome page
S. Brierley-Hobson
Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancer
Bioscience Horizons, March 1, 2008; 1(1): 9 - 18.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Derks, C. Postma, B. Carvalho, S. M. van den Bosch, P. T.M. Moerkerk, J. G. Herman, M. P. Weijenberg, A. P. de Bruine, G. A. Meijer, and M. van Engeland
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations
Carcinogenesis, February 1, 2008; 29(2): 434 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
S. Ogino and A. Goel
Molecular Classification and Correlates in Colorectal Cancer
J. Mol. Diagn., January 1, 2008; 10(1): 13 - 27.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.